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 Summary
	 Background:  To	 evaluate	 the	 efficacy	 of	 the	 protocol	 of	 combined	 quantitative-qualitative	 analysis	 for	 the	
differentiation	of	focal	hepatic	lesions.			
 Material/Methods:  The	study	group	included	168	patients	with	292	hepatic	lesions	confirmed	by	histology	(n	=138)	or	
follow-up	(n	=154).	Lesions	were	divided	into:	benign	lesions	treated	conservatively	(group	A,	120	
lesions),	malignant	tumors	and	benign	lesions	treated	surgically	(group	B,	172	lesions).	MR	imaging	
(1.5-T)	consisted	of	sequences:	T2	double-echo	TSE,	T2	STIR,	T1	GRE	and	of	dynamic	study.	During	
the	first	part	of	differentiation	process,	quantitative	analysis,	based	on	lesions	T2	relaxation	times	
(derived	 from	T2	double-echo	TSE	 sequence),	was	 performed	 in	 order	 to	 discriminate	non-solid	
lesions	 (hemangiomas,	 cysts,	 abscesses;	 n	=	88)	 from	 solid	 tumors	 (n	=	204).	 Subsequently,	 all	
tumors	 defined	 as	 solid	underwent	qualitative	 evaluation	based	 on	visual	 assessment	 of	 lesions	
signal	intensities	in	all	sequences	and	patterns	of	their	contrast	enhancement.	The	aim	of	this	part	
of	 analysis	was	 to	discriminate	benign	 lesions	 (FNH	and	 focal	 fatty	 infiltration)	 from	other	 solid	
tumors.	The	remaining	tumors	were	characterized	as	group	B	lesions.		
	 Results:	 Statistically	significant	difference	between	mean	T2	relaxation	time	of	solid	tumors	(84.1	ms)	and	
non-solid	lesions	(250.5	ms)	was	noted,	allowing	diagnosis	of	solid	tumors	with	sensitivity	of	96%	
and	specificity	of	93%	(at	the	threshold	of	116	ms).	Overall	202	lesions	were	defined	as	solid	(196	
true	positive,	 8	 false	negative,	 6	 false	positive	 results).	Qualitative	 analysis	 of	 these	 lesions	was	
performed	allowing	correct	characterization	of	all	7	focal	fatty	infiltrations	and	21	of	24	FNH.	Six	
lesions	were	 falsely	 diagnosed	 as	 FNH.	Remaining	 168	 lesions	were	 defined	 as	 group	B	 lesions.	
Both	parts	 of	 differentiation	protocol	 yielded	 sensitivity	 and	 specificity	 of	 92%,	 allowing	 correct	
characterization	of	158	of	172	group	B	lesions.	Fourteen	false	negative	and	10	false	positive	results	
(3	FNH,	1	focal	inflammation,	6	hemangiomas)	were	obtained.	
	 Conclusions:  Combined	protocol	of	quantitative	and	qualitative	analysis	enabled	discrimination	of	group	B	lesions	
(malignant	tumors	and	benign	lesions	treated	surgically)	with	high	sensitivity	and	specificity	of	92%.	
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Background
Computed	 tomography	 (CT)	and	magnetic	 resonance	 (MR)	
are	the	most	commonly	performed	examinations	for	differ-
entiation	of	 focal	 liver	 lesions.	The	 first	 enables	differen-
tiation	of	focal	lesions	within	the	liver	based	on	evaluation	
of	 their	 vascularization	 and	helps	 to	 define	whether	 the	
lesion	 is	well	or	poorly	vascularized	 [1–5].	However,	only	
some	focal	lesions	can	be	explicitly	characterized	by	means	
of	typical	CT	image	(lack	of	enhancement	–	cyst	or	typical	
contrast	 enhancement	 in	multiphase	 exam-most	 heman-
giomas,	FNH)	[5–6].
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In	 comparison	with	 other	 imaging	 techniques,	 the	mag-
netic	 resonance	 is	 a	 complex	 examination	which	 allows	
analysis	of	various	useful	parameters	 in	differential	diag-
nostics	of	liver	tumors,	such	as:	signal	intensity	in	T1	and	
T2-weighted	 images,	dynamics	of	 their	 contrast	 enhance-
ment	 (evaluated	 after	 extracellular	 contrast	 agent	 injec-
tion),	 presence	 or	 lack	 of	 active	hepatocytes	 and	Kupffer	
cells	in	visualized	lesions	after	hepatropic	or	Kupfer	cells-
related	 contrast	 agent	 administration.	Overall	 analysis	 of	
these	parameters	enables	a	more	precise	differentiation	of	
hepatic	tumors.
In	 order	 to	 improve	 the	 efficacy	 of	MR	 examination	 in	
	evaluation	of	 the	 type	of	hepatic	 tumors	we	applied	our	
own	diagnostic	algorithm	of	quantitative	and	qualitative	
analysis.	The	quantitative	analysis	carried	out	in	the	first	
phase	was	based	on	calculations	of	T2	relaxation	times	of	
focal	 lesions	with	 the	use	 of	 double-echo	TSE	 sequence.	
The	aim	was	 to	distinguish	 lesions	of	 long	T2	relaxation	
times	 which	 include	 cysts,	 abscesses	 and	 hemangio-
mas.	The	 second	phase	of	differential	 algorithm	was	 the	
	qualitative	evaluation	of	signal	 intensity	of	 lesions	 in	T1	
and	T2-weighted	images	after	extracellular	contrast	agent	
administration	 in	 different	 phases	 of	 enhancement.	 Its	
aim	was	to	distinguish	the	lesions	with	signal	(in	T1	and	
T2-weighted	images)	typical	for	adipose	tissue	(focal	fatty	
liver)	and	those	matching	criteria	for	focal	nodular	hyper-
plasia	(FNH).	
Aim of study
To	 evaluate	 the	 efficacy	 of	 diagnostic	 algorithm	based	 on	
combined	quantitative-qualitative	 analysis	 differentiation	
of	hepatic	tumors.
Material
The	 analysis	 included	 292	 nodules	 in	 168	 patients	 (80	
men/88	women)	aged	17	to	83	(mean	53).	The	lesions	were	
multiple	in	69	cases,	solitary	in	99;	13	patients	were	diag-
nosed	with	more	than	one	type	of	tumor.	Lesions	are	speci-
fied	in	table	1.
Diagnoses	of	86	patients	were	verified	at	the	histopatho-
logic	 examinations	 of	material	 collected	 during	 surgical	
procedure	(n=64),	biopsy	(n=19)	or	diagnostic	laparosco-
py	 (n=3).	 The	 remaining	 82	 patients,	 including	 cases	 of	
inoperable	lesions	and	focuses	of	image	typical	for	benign	
lesions	 confirmed	 by	 at	 least	 2	 imaging	modalities,	 the	
definite	 diagnosis	was	 based	 on	 correlation	with	 other	
imaging	 procedures,	 control	 examinations	 and	 clinical	
assessment.
128	patients	were	 referred	 for	MR	 scanning	 from	Depart-
ment	of	General,	Transplant	and	Hepatic	Surgery	of	Warsaw	
Medical	University,	others	were	referred	from	other	depart-
ments	 of	 Central	 Clinical	 Hospital	 (n=29)	 or	within	 the	
ambulatory	procedure	(n=11).	
Method
Examinations	were	performed	on	1.5	T	scanner	 (Gyroscan	
ACS	 NT,	 Philips),	 with	 the	 use	 of	 body	 coil.	 The	 follo-
wing	 sequences	 in	 transverse	 plane	 were	 performed	 in	
all	 patients:	 T2-weighted	 TSE	 sequence,	 T2	 Dual	 Echo	
TSE,	T2-weighted	 Inversion	 recovery	with	 fat	 saturation	
(T2	STIR),	T1-weighted	gradient	echo	sequence	(fast	spoiled	
multiplanar	 gradient	 echo,	 T1	 FSMPGRE)	 and	 dynamic	
multiphase	 examination	 of	T1	FSMPGRE	 (for	 parameters	
of	 sequence	 –	 see	 table	 2)	 after	 quick	 hand	 intravenous	
administration	 of	 0.1	 –	 0.15	mmol/kg	 (0.2	 –	 0.3	ml/kg)	 of	
Gd-DTPA.	After	 the	 injection	 IV	 cannula	was	 immediately	
rinsed	 with	 10	 ml	 of	 physiological	 saline.	 Contrast	
Table 1.  Analyzed focal lesion.
Diagnosis Number of lesions Number of patients
Metastases 78 42
Cholangiocarcinoma 59 40
Hemangioma 59 35
hepatocellular 
carcinoma 27 13
FNH 24 15
Cyst 19 19
Abscess 9 8
Hemangiosarcoma 5 1
Focal fatty 
degeneration 7 3
Adenoma 2 2
Mixed tumor 1 1
hydatiform cyst 1 1
Inflammation 1 1
Total 292 181
The sum in „number of patients” column amounts to 181 (instead 
of 168) as 13 patients were diagnosed with more than one type of 
lesion (e.g. hemangioma and metastasis)
Table 2.  Selected parameters of the applied sequences.
Name of sequence images TR/TE (or Teeff) Flip TI  NE TF NSA RG TL (mm) matrix
T2 Dual TSE  T2W 1800/(40/120)  90  -  2 12  2  + 5-7 256
T2 STIR  T2W 1800/100  90 150  1 16  3  + 5-8 256
T1 FSMPGRE  T1W 183/1.8  80  -  1  -  1  - 7 256
TR – time of repetition, TE – time of echo, TEeff – time of echo effective, flipangle, TI –time of inversion , NE – number of echoes, TF – turbo 
factor, NSA – number of signal averages, RG – respiratory gating, TL – slice thickness
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	enhancement	 was	 assessed	 in	 following	 phases:	 arterial	
(20–50	 sec	 after	 the	 injection),	 portal	 vein	 (55–80	 sec),	
	equilibrium	(90–120	sec)	and	delayed	(3–5	min).
Evaluation criteria for results of examinations
In	 order	 to	differentiate	 the	hepatic	nodules	 the	 observed	
lesions	were	divided	 into	2	 groups	 –	 group	A	 consisted	 of	
benign	lesions	treated	conservatively	and	inflammatory	or	
parasitic	lesions,	while	group	B	–	of	malignant	and	benign	
lesions,	their	treatment	of	choice	being	the	surgical	proce-
dure.	Differentiation	consisted	of	discrimination	of	A-group	
lesions;	 other	 lesions	 were	 automatically	 qualified	 for	
group	B.	Table	 3	 shows	 classification	of	 focal	 lesions	 that	
we	used.
The	process	of	differentiation	consisted	of	2	phases	–	quan-
titative	analysis	and	qualitative	analysis.
Quantitative	assessment	based	on	analysis	of	T2	relaxation	
times	of	focal	lesions
In	 order	 to	 quantitatively	 analyze	 the	 focal	 lesions,	 they	
were	divided	into	two	groups	–	solid	tumors	(characterized	
by	 T2	 relaxation	 times)	 and	 other	 tumors:	 hemangiomas	
and	liquid	 lesions	 including	cysts	and	abscesses	 (characte-
rized	by	longer	T2	relaxation	times)	(table	4).
Quantitative	analysis	consisted	of	calculations	of	transverse	
relaxation	times	(T2)	of	tumors	made	on	the	basis	of	mea-
surements	 of	 their	 signal	 intensity	 in	T2	Dual	Echo	TSE	
sequence.	For	each	of	 the	echoes	 two	measurements	were	
taken	and	 then	averaged.	Region	of	 interest	 (ROI)	 covered	
the	 possibly	 largest	 part	 of	 tumor.	 In	 solid-liquid	 lesions	
ROI	was	 limited	 to	 the	 solid	part	of	 tumor.	The	 following	
equation	was	used	for	calculations:
T2 (ms) = (TE 2 – TE 1) / (ln SI 1 – ln SI 2)
TE 1	stands	for	time	of	the	first	echo	(40ms),	TE 2-for	time	
of	the	second	echo	(120	ms),	and	In SI 1 and In SI 2 are	the	
natural	 logarithms	of	 signal	 intensity	obtained	 in	 the	 first	
and	second	echo.	Calculations	were	made	using	the	Excell	
spreadsheet	(Microsoft	Office	software).
Next,	 optimal	 threshold	 value	 was	 determined	 in	 order	
to	 discriminate	 solid	 tumors	 (characterized	 by	 short	 T2	
times)	 from	other	 lesions	 (long	T2	 times)	with	 the	highest	
possible	 sensitivity	and	specificity.	Moreover,	 solid	 lesions	
with	shortest	T2	relaxation	times	 indicating	 focal	nodular	
hyperplasia	 (FNH)	were	 also	 distinguished.	 According	 to	
our	hypothesis,	 lesions	built	 of	 normal	hepatocytes	 ought	
to	be	characterized	by	short	T2	relaxation	times,	similar	to	
hepatic	parenchyma.	The	second	additional	threshold	value	
was	 determined	 to	 discriminate	 FNH	 from	 other	 lesions	
with	optimal	sensitivity	and	specificity.	
Statistic	analysis	was	carried	out	with	the	use	of	t-student	
test	in	order	to	evaluate	statistical	significance	of	mean	T2	
relaxation	 times	 of:	 (1)	 solid	 tumors,	 angiomas	 and	 cystic	
lesions,	(2)	FNH	and	other	solid	tumors.
Qualitative	analysis
It	was	 the	 second	 stage	 of	 differentiating	 focal	 lesions	
and	 included	 202	 lesions	 qualified	 at	 the	 quantita-
tive	 stage	 to	 the	 group	 of	 solid	 tumors	 (on	 the	 basis	 of	
T2	 relaxation	 times	 shorter	 than	 threshold	 value).	 The	
aim	of	the	qualitative	analysis	was	to	discriminate	focal	
fatty	liver	and	focal	nodular	hyperplasia	from	the	group	
of	 solid	benign	 lesions.	Qualitative	analysis	 consisted	of	
visual	assessment	of	signal	of	 focal	 lesions	 in	particular	
sequences,	before	and	after	intravenous	administration	of	
Gd-DTPA.	It	was	carried	out	by	two	radiologists	and	the	
final	 result	was	 based	 on	 the	 principle	 of	 unanimity	 of	
observers.
The	 only	 diagnosis	 criterion	 for	 focal	 fatty	 liver	 was	
the	 detection	 of	 lesion	 characterized	 by	 elevated	 or	
Table 4.  Classification of focal lesions by their solid or non-solid 
character.
Solid tumors (n = 204) Other types of lesions (n = 88)
Metastases
Hepatocellular carcinoma
Cholangiocarcinoma 
Hemangiosarcoma
Focal nodular hyperplasia (FNH)
Adenoma
Focal fatty liver
Inflammation
Hemangioma
Cyst
Hydatiform cyst
Abscess
Table 3. Established classification of focal hepatic lesions. 
Group A (n = 120) Group B (n = 172)
Hemangioma
Cyst
Hydatiform cyst
Abscess
Focular nodula hyperplasia (FNH)
Focal fatty liver
Inflammation
Metastases
Hepatocellular carcinoma
Cholangiocarcinoma 
Hemangiosarcoma
Adenoma
Figure 1.  Protocol for the differentiation of focal liver lesions.
1. Quantitative analysis (T2 relaxation times)
> Threshold value < threshold value
Hemangiomas/cystic lesions
2. Qualitative analysis
FNH/focal fatty live
other tumors
malignant tumors/benign tumors treated surgically
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	moderate	 signal	 in	T1-weighted	 images	which	 presents	
weakening	of	the	signal	in	sequence	with	fat	saturation.
For	 FNH	 recognition	 the	 following	 criteria	 were	 taken	
into	account:	 (1)	short	T2	time,	below	the	threshold	value	
of	 FNH,	 (2)	 isointensity	 or	 moderate	 hypointensity	 in	
T1-weighted	 images,	 (3)	 strong	homogenous	 enhancement	
in	 the	 arterial	 phase,	 (4)	 isointensity	 in	 equilibrium	 and	
delayed	phases.	Three	matching	 criteria	 out	 of	 four	were	
considered	 as	 FNH	 recognition.	Additionally,	 incidence	 of	
central	 scar	was	 also	 analyzed	 in	FNH	cases	 although	 its	
presentation	was	not	a	necessary	condition	for	focal	nodu-
lar	hyperplasia	diagnosis.	
Lesions	which	 did	not	match	 the	 criteria	 for	 focal	 fatty	
liver	 or	 FNH	diagnosis	 and	were	 not	 previously	 (in	 the	
quantitative	phase)	qualified	for	cyst	and	angioma	group,	
were	 diagnosed	 as	malignant	 or	 benign	 tumors	 treated	
surgically	 (group	 B).	 For	 outline	 of	 differential	 process	
–	see	table	1.
Statistic analysis
Statistic	 analysis	 of	 results	 was	 based	 on	 parametric	
t-Student	 tests	 for	 independent	 samples.	The	 significance	
level	was p<0.05.	All	calculations	and	analyses	were	con-
ducted	using	statistic	software	package	of	STATISTICA	6.0	
(StatSoft	Poland).
Results
Quantitative analysis of T2 relaxation times of focal 
lesions
T2	relaxation	times	of	liver,	solid	tumors	and	other	lesions	
(angiomas,	 cysts,	 abscesses)	 in	 the	 analyzed	 group	 of	 292	
lesions	in	168	patients	are	depicted	in	table	5.	
Statistically	significant	difference	was	noted	between	mean	
T2	 relaxation	 time	 of	 solid	 tumors	 and	mean	T2	 time	 of	
hemangiomas,	 cysts	 and	 abscesses	 analyzed	 together	
(p<0.0000001).	
Optimal	 threshold	value	discriminating	 solid	 tumors	 from	
other	lesions	proved	to	be	the	T2	time	–	116	ms	for	which	
the	 sensitivity	 amounted	 to	 96%	 and	 specificity	 to	 93%	
(accuracy	95%,	positive	prognostic	value	97%,	negative	pro-
gnostic	value	91%).
Figure	 2	 shows	 T2	 relaxation	 times	 of	 solid	 tumors	 and	
other	lesions	(hemangiomas,	cysts,	abscesses).	
In	the	examined	group	of	292	focal	lesions	in	168	patients,	
8	 of	 204	 solid	 tumors	were	 falsely	 qualified	 to	 the	 group	
of	 other	 lesions	 (hemangiomas,	 cysts,	 abscesses)	 based	 on	
transverse	relaxation	time	(T2)	longer	than	threshold	value	
(116	ms).	 All	 8	 tumors	were	 focuses	with	 dimensions	 of	
8	to	180	mm	which	derived	from	large	intestine	carcinoma	
(3	focuses),	melanoma,	 carcinoid,	 praganglioma,	 neuroen-
docrinal	 carcinoma	or	 neoplasm	of	 unknown	 source.	The	
dimensions	of	2	of	the	tumors	exceeded	100	mm	(180	mm	
and	150	mm),	the	next	measured	87	mm	and	the	remaining	
5	did	not	exceed	30	mm.	
As	for	the	3	biggest	tumors	(2	metastases	of	large	intestine	
carcinoma	and	1	carcinoma	of	an	unknown	source)	necro-
sis	 occupying	most	 of	 the	altered	area	was	 the	 reason	 for	
longer	transverse	relaxation	time.	In	spite	of	measuring	the	
signal	intensity	in	their	peripheral	solid	part,	the	relaxation	
times	were	 longer	 and	 typical	 for	 hemangiomas	 or	 cystic	
lesions.	Among	5	 smaller	 tumors	 3	 presented	 rich	 vascu-
larization	 in	multiphase	 examination	 after	 paramagnetic	
	contrast	 agent	 administration	 (metastases	 of	 carcinoid,	
paranglioma,	 or	neuroendocrine	 tumor).	 Such	vasculariza-
tion	could	be	the	reason	why	their	T2	relaxation	times	were	
elongated,	although	other	18	well-vascularized	metastases	
in	 the	 examined	 population	 were	 characterized	 by	 rela-
xation	 times	shorter	 than	threshold	value	 (116	ms).	 In	 the	
analyzed	group	of	78	metastatic	lesions	mean	T2	relaxation	
time	 of	well-vascularized	metastases	was	 longer	 (97	ms)	
than	mean	 time	of	T2	 relaxation	 times	 of	 poorly	vascula-
rized	metastases	 (91.8	ms)	but	 the	difference	was	not	sta-
tistically	significant	(p<0.22).	The	remaining	2	(metastases	
of	large	intestine	carcinoma	and	melanoma)	out	of	8	falsely	
qualified	to	the	group	of	lesions	other	than	solid,	were	cha-
racterized	by	poor	vascularization.	
Among	 88	 tumors	 other	 than	 solid,	 transverse	 relaxation	
times	of	6	hemangiomas	were	shortened	and	fit	in	the	range	
typical	for	solid	tumors.	The	size	of	the	biggest	hemangioma	
was	202	mm;	sizes	of	other	5	varied	from	7	to	14	mm	(mean	
–	10	mm).	in	the	first	case	massive	hemangioma	of	the	liver	
imitated	 a	malignant	 tumor	with	 central	 necrosis	 in	MR	
examination.	The	peripheral	part	of	the	lesion	was	charac-
terized	by	 lower	 signal	 intensity	 (shorter	T2	 time),	 typical	
for	solid	lesions.	Histopathologic	examination	revealed	that	
this	 part	 of	 the	 hemangioma	was	 covered	with	hyaliniza-
tion	and	 fibrosis	which	shortened	T2	 relaxation	 time.	 In	5	
other	cases	of	 small	hemangiomas	 (mean	10	mm)	 the	most	
	
Figure 2.  Mean T2 times of solid lesions (84 ms) and other tumors 
(250.5 ms).
Table 5. Mean T2 relaxation times of liver and focal hepatic lesions.
Mean T2 time (ms) Range (ms)
Liver 54 41 – 74
Solid tumors 84.1 54 – 148
Other lesions 250.5 82 – 1241
* hemangiomas, cysts, abscesses
Mean 
±Standard deviation
±1,96 Standard deviation
Solid tumors other lesions
-200
-100
0
100
200
300
400
500
600
700
30
Pol J Radiol, 2007; 72(1): 26-35Original Article
	probable	reason	of	false	classification	was	the	effect	of	volu-
me	averaging	effect	–	the	coil	embraces	the	parts	of	hepatic	
parenchyma	which	 are	 adjacent	 to	 lesions	 and	have	 shor-
ter	T2	times	(fig.	3).	Generally,	19	of	24	small	hemangiomas	
with	the	maximum	size	smaller	than	15	mm	were	correctly	
classified	to	the	group	of	lesions	other	than	solid	(including	
10	out	of	13	angiomas	smaller	than	11	mm).	
T2	relaxation	times	of	particular	types	of	focal	 lesions	are	
depicted	in	table	6.
In	the	group	of	solid	lesions,	nodular	hyperplasia	was	cha-
racterized	by	weakest	signal	and	mean	T2	relaxation	time	
closer	to	the	liver	(63.7	ms),	but	shorter	compared	to	other	
solid	tumors	(86.8	ms).	The	difference	was	statistically	sig-
nificant	(p	<	0.0000001).	Threshold	value	of	68	ms	enabled	
recognition	 of	 FNH	with	 sensitivity	 of	 83%,	 specificity	 of	
93%	and	accuracy	of	92%.
The	differences	between	mean	T2	relaxation	times	were	also	
found	 in	 cases	 of	 solid	 tumors	 such	 as	hepatocellular	 car-
cinoma,	 cholangiocarcinoma	and	metastases.	However,	we	
failed	 to	 define	 a	 threshold	 value	which	would	 enable	 its	
discrimination	with	satisfying	sensitivity	and	specificity,	the	
reason	being	wide	scope	of	T2	relaxation	times	of	the	afore-
mentioned	tumors	which	hindered	their	differentiation.
In	 general,	 quantitative	 analysis	 of	 transverse	 relaxation	
times	 of	 292	 focal	 lesions	 (204	 solid	 tumors,	 88	 lesions	 of	
other	 type)	with	threshold	value	of	116	ms,	enabled	accu-
rate	diagnosis	of	82	of	88	hemangiomas,	cysts	and	absces-
ses	with	8	false	positive	results	(sensitivity	83%,	specificity	
93%).	Moreover,	determination	of	second	threshold	value	of	
68	ms	allowed	accurate	diagnosis	of	20	of	24	FNH	with	12	
false	positive	recognitions	(sensitivity	83%,	specificity	93%).
Qualitative analysis of focal lesions
This	analysis	 included	202	 focal	 lesions	with	 relaxation	 times	
shorter	than	116	ms	(196	solid	lesions,	6	hemangiomas)	quali-
fied	to	the	group	of	solid	lesions	based	on	quantitative	analysis.
Diagnostics of focal fatty infiltration
All	7	 focuses	of	 fatty	 infiltration	 found	 in	3	patients	mat-
ched	the	diagnostic	criteria	for	this	type	of	lesion	(elevated	
Table 6. T2 relaxation times of focal lesions in analyzed material. 
Recognition Number of lesions Number of patients Mean T2 time (ms) Range (ms)
SOLID TUMORS
Metastases 78 42 93.2 56 – 148
Cholangiocarcinoma 59 40 85 64 – 110
Hepatocellular carcinoma 27 13 75.3 56 – 91
FNH 24 15 63.7 54 – 75
Hemangiosarcoma 5 1 89 76 – 113
Fatty infiltration 7 3 78.7 68 – 85
Adenoma 2 2 74 62 – 86
Mixed tumor 1 1 68 68
Inflammation 1 1 69 69
OTHER LESIONS
Hemangioma 59 35 151.3 82 – 249
Cyst 19 19 576.6 180 – 1241
Abscess 9 8 238.6 145 – 301
Hydatiform cyst 1 1 117 117
Figure 3.  Small hemangioma (arrow) with short, T2 time (103 ms), due 
to volume averaging effect.
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or	moderate	signal	intensity	in	T1-weighted	images	and	its	
lowering	 in	 sequence	 of	 adipose	 tissue	 saturation)	 (fig.	4).	
False	positive	results	were	not	stated	(sensitivity,	specifici-
ty,	accuracy	–	100%).
Diagnostics of focal nodular hyperplasia
After	 depiction	 of	 7	 lesions	with	 typical	MR	 features	 of	
focal	fatty	infiltration	the	analyzed	group	consisted	of	195	
focal	 lesions	 (24	FNH,	165	other	 solid	 tumors,	 6	heman-
giomas).
Twenty	one	of	24	FNH	cases	matched	at	least	3	criteria	for	
its	 recognition	 (14	matched	4	diagnostic	 criteria	 for	FNH)	
(fig.	5).	Another	3	 lesions	matched	only	2	of	4	criteria	and	
were	 therefore	 the	 false	 negative	 results.	 The	 analyzed	
group	included	6	lesions	other	than	FNH	which	agreed	with	
at	 least	 3	 diagnostic	 criteria	 for	 this	 type	 of	 lesion	 (false	
positive	results):	4	metastases	(including	1	secondary	focus	
of	 cholangiocarcinoma),	 1	 primary	 focus	 of	 hepatocellular	
carcinoma,	 1	 adenoma).	 Two	 of	 these	 lesions	 (metastases	
of	melanoma,	 focus	 of	 hepatoma)	matched	 4	 criteria	 for	
FNH	diagnosis.	The	sensitivity	was	88%,	specificity	–	97%,	
positive	prognostic	value	–	78%,	negative	prognostic	value	
–	98%,	accuracy	–	95%.	
The	 symptom	most	 frequently	 observed	 in	 FNH	 focuses	
(22	out	of	24	cases	–	95%)	was	early	homogenous	enhance-
ment	of	 lesion	 in	the	arterial	phase	which	did	not	 include	
	central	scar	(provided	the	scar	was	noticeable).	Isointensity	
Figure 4.  Focal fatty infiltration liver of liver hilum, with slightly increased signal intensity (arrow) in T2 Dual Echo TSE sequence (A), isointense 
sequence with fat saturation – T2 STIR (B).
A B
Figure 5.  Focal nodular hyperplasia of the liver in sequences: T2 Dual Echo TSE (A), T1 GRE (B), T1 GRE – arterial phase (C), T1 GRE 
– parenchymal phase (D). This lesion is seen only in arterial phase of contrast enhancement (arrow – C).
A B
C D
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in	equilibrium	and	delayed	phases	was	observed	in	88%	of	
cases	 (21	 cases).	 T1–weighted	 images	 showed	FNH	 isoin-
tensive	 in	 relation	 to	 the	 liver	 in	 62%	 and	hypointensive	
in	 38%	 of	 cases.	 On	 T2-weighted	 images	 tumors	 were	
	hyperintensive	in	58%	and	isointensive	in	42%	of	cases.
The	 central	 scar	 was	 observed	 equally	 often	 on	 T2-
weighted	 images	 as	 in	 the	 arterial	 phase	 of	 contrast	
	enhancement	(each	in	9	cases	–	38%),	but	less	frequently	on	
T1-weighted	 images	and	in	delayed	phase	 (each	 in	7	cases	
–	29%)	and	also	on	T1-weighted	images	(6	cases	–	25%).	The	
scar	was	hipointensive	 on	T2-weighted	 images	but	 in	 the	
arterial	phase	an	unenhanced	(hipointensive)	structure	was	
visible.	 In	 6	 of	 7	 cases	 the	 scar	was	noticeable	 in	 paren-
chyma/delayed	phases	as	an	area	accumulating	the	contrast	
agent	(hiperintensive),	while	in	1	case	–	as	a	hipointensive	
structure.	
Therefore,	 in	 the	 group	 of	 202	 tumors	 classified	 as	 solid	
lesions	 (196	 true	 positive	 results	 and	 6	 falsely	 positive)	
correct	 diagnosis	was	made	 for	 all	 7	 cases	 of	 focal	 fatty	
liver	 (sensitivity	 and	 specificity	 –	 100%),	 21	 of	 24	 FNH	
cases	 (sensitivity	 –	 88%,	 specificity	 –	 97%)	 and	FNH	was	
	falsely	 diagnosed	 in	 6	 cases.	 The	 remaining	 168	 lesions	
of	 T2	 relaxation	 times	 shorter	 than	 116	ms,	which	were	
	neither	recognized	as	focuses	of	fatty	infiltration	nor	FNH,	
were	qualified	to	the	B	group	(malignant	or	benign	tumors	
	treated	 surgically).	This	 group	 consisted	 of	 158	 true	posi-
tive	and	10	false	positive	results.
In	 general,	 the	 use	 of	 presented	 quantitative-qualitative	
analysis	 system	 for	 recognition	of	B	 group	 tumors	 (malig-
nant	 and	 benign	 lesions	 treated	 surgically)	 allowed	us	 to	
obtain	158	true	positive	diagnoses,	110	true	negative	diag-
noses	(82	lesions	other	than	solid	with	T2	relaxation	times	
>	 116	ms,	 7	 fatty	 liver	 focuses,	 21	 FNH),	 10	false	 posi-
tive	 results	 (6	hemangiomas	with	shortened	T2	relaxation	
times	 <	 116	 ms,	 3	 FNH,	 1	 inflammation)	 and	 14	 false	
negative	 results	 (8	metastatic	 tumors	with	 elongated	 T2	
relaxation	 times	>116	ms,	 6	 solid	 tumors	 fulfilling	 FNH	
recognition	 criteria).	 Sensitivity,	 specificity	 and	 accu-
racy	 of	 the	B	 group	 tumor	 recognition	 amounted	 to	 92%,	
positive	 prognostic	 value	 –	 94%	 and	 negative	 prognostic	
value	–	89%.	
Discussion
The	 optimal	 technique	 for	 hepatic	 focal	 lesions	 imaging	
ought	 to	 be	 characterized	 by	high	 sensitivity	 and	 speci-
ficity	 of	 detection,	 as	well	 as	 accuracy	 in	 assessment	 of	
character	of	the	lesions.	High	specificity	is	especially	sig-
nificant	 for	 recognition	 of	most	 common	benign	 lesions	
(hemangioma,	 cyst,	FNH),	 as	 it	 enables	 to	 cancel	 out	 the	
presence	 of	malignant	 tumor	 and	 complete	 the	 imaging	
diagnostics.	 Among	 imaging	 techniques,	MR	 is	 the	 one	
that	 helps	 to	 obtain	 the	 best	 possible	 contrast	 between	
normal	hepatic	parenchyma	and	pathologic	tissues,	espe-
cially	on	T2	–weighted	images.	
Hemangioma	is	the	most	common	focal	lesion	in	the	liver	
and	occurs	in	2–20%	of	population	[7–9].	MR	examination	
is	especially	significant	in	cases	of	angiomas	which	do	not	
present	 typical	 features	 in	USG	 (20%)	 and	CT	 (30–35%)	
examinations.	 In	MR	 the	 diagnosis	 of	 angioma	 consists	
in	 assessment	 of	 two	parameters:	 typical	 enhancement	
after	 intravenous	 paramagnetic	 contrast	 administration	
and	strong	hiperintensity	on	T2-weighted	images	[10–13].	
Both,	 qualitative	 and	quantitative	 analyses	 of	T2-weig-
hted	 images	 are	 also	 possible.	 Qualitative	 analysis	 is	
used	more	 frequently	 as	 it	 does	 not	 require	 additional	
calculations.	 Such	 approach	 is	 justified	 by	 convenience	
and	 shorter	 time	needed	 for	 qualitative	 analysis	 rather	
than	by	rationale.	Fenlon	et	al.	compared	the	efficacy	of	
qualitative	 and	 quantitative	 analyses	 in	 differentiation	
of	focal	lesions	in	liver	with	the	use	of	strongly	T2-weig-
hted	sequences	of	spin	echo	and	proved	a	higher	efficacy	
of	 quantitative	 analysis	 in	 assessment	 of	 lesions	 of	 the	
type	[14].	
Until	 recently	T2	weighted	 sequences	 (TE	150	ms)	were	
used	 for	 qualitative	 and	 quantitative	 analyses	 as	 they	
were	 considered	 best	 for	 differentiating	 angiomas	 and	
solid	 tumors	 [10,	 14–16].	 However,	 sequences	 of	 lower	
T2	weight	 (TE	≤	120	ms)	are	more	precise	 in	recognition	
of	 solid	hepatic	 tumors	due	 to	optimal	 contrast	between	
the	lesion	and	parenchyma	[10].	Until	recently	it	has	been	
believed	 that	 including	 both	 –	moderately	 and	 strongly	
T2-weighted	 sequences	 in	 the	 protocol	 of	 examination	
was	 necessary	 for	 accurate	 assessment	 of	 number	 and	
character	of	focal	lesions	in	liver	[10,	15].	Obtained	results	
seem	to	negate	 the	above	reason	as	 they	prove	 that	pre-
cise	 differentiation	 of	 focal	 lesions	 is	 possible	with	 the	
use	of	moderate	T2-weighted	TSE	sequence	(T2	Dual	Echo	
TSE),	which	was	also	successfully	used	 to	detect	 tumors	
in	liver.
Quantitative	 analysis	 seems	necessary	 in	 order	 to	 assure	
efficacy	 of	 this	 sequence	 in	 differential	 diagnostics	 of	
hepatic	tumors.	In	the	examined	group	of	168	patients	(out	
of	292)	with	focal	lesions	located	in	liver	the	T2	dual	echo	
TSE	 sequence	 showed	high	 accuracy	 (95%)	 in	 differentia-
tion	between	solid	 tumors	and	angiomas	or	cystic	 lesions.	
Another	 advantage	 of	 this	 technique	 is	 the	 simplification	
and	 shortening	 of	 MR	 examination	 protocol	 in	 patients	
with	hepatic	tumors,	which	is	achieved	by	means	of	omit-
ting	strong	T2	sequence	that	was	supposed	to	discriminate	
cysts	and	hemangiomas	from	solid	tumors.
In	the	described	material	6	of	59	hemangiomas	(10%)	were	
falsely	 qualified	 to	 the	 group	 of	 solid	 tumors	 the	 basis	
being	their	untypical	short	T2	relaxation	times	(<116	ms).	
On	 the	 other	 hand,	 quantitative	 analysis	 enabled	differ-
entiation	 of	 cysts	 and	 abscesses	 from	 solid	 tumors	with	
100%	specificity.	No	cases	of	lesions	with	shortened	trans-
verse	 relaxation	 times	were	stated	 in	 the	cysts/abscesses	
group	and	 their	 average	T2	 times	 (abscesses	 –	 238.6	ms,	
cysts	–	576.6)	were	significantly	longer	than	T2	of	heman-
giomas	(151.3	ms).	
Solid	hepatic	 tumors	 are	 in	most	 cases	malignant	 lesions.	
The	most	 significant	 exceptions	 from	 this	 rule	 are	benign	
solid	tumors,	such	as	adenoma	and	focal	nodular	hyperpla-
sia	or	malignant	cystic	tumors,	e.g.	cystic	adenocarcinoma	
of	 biliary	 ducts.	Adenoma	 is	 a	 rare	 tumor,	 in	 some	 cases	
complicated	with	 life-threatening	 hemorrhage	 or	 far	 less	
frequently	–	with	transformation	into	malignant	neoplasm	
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[7–8,	17–18].	Differentiation	between	this	kind	of	tumor	and	
malignant	 lesions	does	not	significantly	 influence	the	way	
of	 treatment	 as	 both	 –	 the	 adenoma	and	operative	malig-
nant	 tumors	 –	 are	 treated	by	means	 of	 surgical	 resection	
[18].	Focal	nodular	hyperplasia,	although	more	frequent	 in	
population,	does	not	carry	risks	like	the	adenoma	and	does	
not	require	treatment.	
Therefore,	it	is	incredibly	important	to	differentiate	FNH	
from	other	solid	tumors	which	require	surgical	treatment	
(adenoma,	 malignant	 tumors).	 On	 T1	 and	 T2-weighted	
images	the	FNH	is	characterized	by	signal	intensity	simi-
lar	 or	 same	as	 the	 liver.	T2	 relaxation	 times	 of	FNH	are	
in	most	 cases	 shorter	 than	T2	 relaxation	 times	 of	 other	
solid	tumors.	In	the	analyzed	material	of	204	solid	lesions	
the	mean	T2	relaxation	time	of	FNH	(63.7	ms)	was	signifi-
cantly	shorter	than	mean	T2	relaxation	time	of	other	solid	
tumors	(86.8	ms)	(p	<	0000001).	With	the	threshold	value	
of	 68	ms	 4	 false	 negative	 and	 12	 false	 positive	 recogni-
tions	were	noted	 (sensitivity	 83%,	 specificity	 93%,	 accu-
racy	92%).	
Quantitative	analysis	of	transverse	relaxation	times	of	focal	
lesions	in	liver	also	carries	certain	potential	disadvantages	
which	 can	 lead	 to	 improper	 recognitions.	Hemngioma	can	
be	falsely	classified	as	solid	tumor	in	two	situations.
First,	in	case	of	small	lesions	(<11	mm)	T2	relaxation	time	
can	 be	 shortened	 as	 a	 result	 of	 partial	 occupancy	which	
consists	 in	 covering	not	 only	 the	hemangioma	 (with	 long	
T2	relaxation	time)	in	the	examined	section	but	also	a	part	
of	hepatic	parenchyma	(with	short	T2	relaxation	time).	As	a	
result	mean	T2	time,	often	shorter	than	the	threshold	value	
(116	ms	in	the	examined	group)	is	obtained.	The	use	of	thin	
layers	 (5–6	mm)	 in	most	 cases	helps	 to	 reduce	 the	partial	
occupancy	 effect	 to	minimum	with	 simultaneous	 lack	 of	
noticeable	 worsening	 in	 quality	 of	 the	 obtained	 images.	
Among	24	analyzed	small	angiomas	(<15	mm)	true	positive	
recognitions	were	made	 for	19	of	 them	while	 the	T2	rela-
xation	 times	of	 the	 remaining	5	 fit	 into	 the	 range	of	 solid	
lesions	(fig.	3).	
The	 second,	 less	 frequent	 reason	 of	 misdiagnosis,	 was	
hemangioma	covered	with	 fibrosis	 or	hyalinization.	These	
regions	can	imitate	solid	parts	of	malignant	tumors	covered	
by	decomposition	what	took	place	in	case	of	a	solitary	large	
angioma	in	which	the	histopathologic	examination	showed	
regions	of	fibrosis	and	hyalinization.
The	 inverse	 situation	 –	 false	 recognition	 of	 hemangioma	
–	is	 possible	 with	 malignant	 tumors	 almost	 entirely	
	covered	with	decomposition	or	richly	vascularized	metas-
tases,	 often	 characterized	 by	 elongated	 T2	 relaxation	
times.	 In	 cases	 of	 tumors	 which	were	 decomposed	 the	
measurements	 ought	 to	 be	 taken	 in	 the	peripheral	 parts	
which	often	keep	 the	 solid	 character.	 In	3	 cases	 of	 large	
metastases	 altered	with	necrosis	 the	 obtained	T2	 relax-
ation	 times	were	 typical	 for	 angiomas	 in	 spite	 of	 taking	
the	measurements	 in	 the	marginal	 parts	which	 did	 not	
contain	enough	solid	tissue.	
According	 to	 some	 authors,	 several	 richly	 vascularized	
tumors	are	characterized	by	elongated	T2	relaxation	times	
[19–20].	In	the	analyzed	material,	3	of	21	well	vascularized	
metastases	 presented	 transverse	 relaxation	 times	 typical	
for	 hemangiomas.	Moreover,	 small,	 statistically	 insignifi-
cant	 differences	 concerning	T2	 relaxation	 times	 of	 richly	
vascularized	metastases	 (97	ms)	 and	 poorly	 vascularized	
(91.8	ms)	were	also	indicated.	
Apart	 from	 the	 mentioned	 6	 false	 negative	 results	 of	
solid	 lesions	 the	 studied	material	 also	 contained	2	small	
(<30	 mm),	 poorly	 vascularized	 tumors	 (metastases	 of	
large	 intestine	carcinoma	and	melanoma)	with	 longer	T2	
times	 (>116).	In	case	of	these	lesions	it	was	not	possible	
to	determine	the	possible	reason	of	their	T2	times	elonga-
tion.
Despite	these	disadvantages	of	the	method,	the	results	pro-
ved	 that	 quantitive	 analysis	 of	 hepatic	 lesions	 is	 a	 very	
useful	technique	for	assessment	of	their	character.	Similar	
conclusions	were	presented	by	authors	of	other	reports	on	
evaluation	of	utility	of	quantitive	analysis	in	differentiation	
of	focal	lesions	[14,	21–23].
In	the	second	phase	of	hepatic	tumors	differentiation	based	
on	 qualitative	 analysis	 all	 7	 focuses	 of	 fatty	 infiltration	
were	confirmed	on	the	basis	of	applied	evaluation	criterion	
–	 the	 signal	 identical	 or	 similar	 to	 adipose	 tissue	 (subcu-
taneous,	 retroperitoneal)	 signal	 in	 all	 examined	 sequences	
(sensitivity	100%).	Other	lesions	of	identical	signal	were	not	
observed	(specificity	100%).	
Focal	nodular	hyperplasia	(FNH)	is	the	third	most	frequent	
(after	cyst	and	hemangioma)	benign	lesion	which	occurs	in	
liver	 and	 constitutes	 8%	of	 all	 primary	hepatic	 lesions.	 It	
is	 far	more	often	found	 in	women	than	 in	men,	especially	
between	3rd	and	5th	decade	of	life.	It	is	a	nodular	formation	
with	 no	 capsule	 created	 by	 normal	 hepatocytes	 focused	
around	 fibrous	 central	 scar.	 FNH	contains	 all	 elements	 of	
normal	liver	parenchyma	but	their	organization	and	archi-
tecture	diverges	from	the	standard	[7–8,	17].	
The	CT	and	USG	image	of	the	FNH	is	not	specific.	Although	
the	 presence	 of	 central	 scar	 is	 considered	 to	 be	 a	 typical	
symptom	for	this	lesion,	it	 is	only	noticeable	in	33–50%	of	
imaging	 examinations	 (USG,	 CT,	MR)	 [5–6,	 24].	However,	
even	 in	 case	 of	 its	 detection	 it	 is	 not	possible	 to	definite-
ly	 differentiate	 FNH	 from	malignant	 solid	 tumors	which	
can	 contain	 central	 scar	 as	well	 (hepatocellular	 carcino-
ma,	 especially	 its	 fibrolamellar	 form,	 cholangiocarcinoma,	
large	hemangiomas).	 In	 the	 examined	material	 the	 central	
scar	was	 found	only	 in	about	1/3	of	 cases.	 It	was	 charac-
terized	by	hiperintensity	 on	T2-weighted	 image	 and	 typi-
cal	 contrast	 enhancement	 –	 unlike	 the	 remaining	 part	 of	
the	 tumor,	 it	 was	 saturated	 by	 the	 contrast	 agent	 after	
the	 delayed	 phase	 due	 to	 the	 presence	 of	 connective	 tis-
sue.	Considering	 the	 low	sensitivity	and	specificity	of	 this	
symptom,	 it	was	not	 included	 in	FNH	diagnostic	 criteria.	
Detection	of	scar,	as	well	as	typical	age	and	sex	of	a	patient	
(women	aged	20	 –	 50)	 can	be	 the	 additional	 factor	which	
suggests	correct	diagnosis.	
The	FNH	recognition	in	MR	examination	requires	complex	
analysis	 of	 several	 parameters	 (T2	 relaxation	 time,	 signal	
intensity	on	T1-weighted	images,	contrast	enhancement	in	
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particular	phases	of	dynamic	examination).	In	the	examined	
group	of	patients	the	most	common	FNH	features	included	
homogenous	and	temporary	enhancement	in	arterial	phase	
(92%	of	lesions)	and	isointensity	in	equilibrium	and	delayed	
phases	 (88%	of	 cases).	 Such	 image	 is	not	 specific	 for	FNH	
and	can	also	be	observed	in	other	tumors	–	richly	vasculari-
zed	metastases	and	primary	tumors	(early	HCC)	[17,	25].	The	
specificity	of	FNH	recognition	significantly	increased	when	
other	 criteria,	 such	 as	 T2	 relaxation	 times	 (below	 thres-
hold	value	 of	 68	ms)	 and	 signal	 intensity	 on	T1-weighted	
images,	 were	 taken	 into	 consideration.	 Signal	 intensity	
identical	or	similar	to	liver	on	T1	and	T2-weighted	images	
is	a	distinctive	feature	of	FNH.
In	the	examined	group	of	patients	the	lesions	were	isointen-
sive	 in	 relation	 to	 liver	 on	62%	of	T1-weighted	 images	 and	
42%	 of	 T2-weighted	 images.	 Most	 of	 the	 remaining	 FNH	
lesions,	 although	 not	 isointensive,	 were	 characterized	 by	
slight	hipointensity	 (on	T1-weighted	 images)	 or	hiperinten-
sity	 (on	T2-weighted	 images)	and	short	T2	relaxation	 times	
(mean	63.7	ms)	[26].	The	system	of	complex	qualitative	ana-
lysis	that	we	introduced,	based	on	completion	of	3	of	4	crite-
ria	set	for	recognition	of	this	lesion,	showed	high	sensitivity,	
specificity	and	accuracy	(respectively	88%,	97%,	95%).
Adenoma	is	a	lesion	which	occurs	in	population	of	patients	
identical	 to	 FNH	 (young	 women),	 but	 less	 frequently.	
Differentiation	of	 these	benign	 lesions	 is	 significant	when	
we	consider	different	ways	of	their	treatment	–	adenomas	
are	treated	surgically	as	there	is	a	risk	of	hemorrhage	and	
sporadic	malignant	 transformation	 [18,27].	Differentiation	
of	 both	 lesions	 is	 not	 problematic	 in	most	 cases	 –	 adeno-
mas	are	usually	larger	tumors	(>5	cm),	heterogeneous	(they	
contain	hemorrhage	 regions	 and/or	 necrosis),	well-vascu-
larized	and	prone	to	mosaic	contrast	enhancement	 [8,	17].	
Misdiagnosis	 is	 possible	 in	 case	 of	 smaller	 adenomas,	 not	
altered	with	hemorrhage	or	decomposition.	
The	smaller	of	2	adenomas	that	we	examined	(dimensions:	
28	mm	and	56	mm),	matched	 the	criteria	 typical	 for	FNH	
recognition.	Discrimination	 of	 such	 lesions	 from	FNH	by	
means	 of	 imaging	 techniques	 can	be	 difficult.	 The	 report	
of	Grazoli	 et	 al.	 published	 recently	 gives	hope	 for	 impro-
vement	 as	 the	 authors	 suggest	 to	 use	 the	 delayed	 phase	
of	 contrast	 enhancement	 after	 Gd-BOPTA	 administration	
(after	1–3	hours)	in	differentiation	of	both	types	of	lesions.	
In	that	phase	96.9%	of	FNH	focuses	were	characterized	by	
hiper-	or	isointensity,	while	all	adenomas	were	hipointensi-
ve	(sensitivity	96.9%,	specificity	100%)	[28].	
One	 of	 the	 limitations	 of	 his	 study	 is	 that	 final	 diagnoses	
of	most	 of	 benign	 lesions	were	 stated	based	 on	 results	 of	
control	 examinations	which	neither	 showed	 their	 growth	
nor	 change	 of	morphology,	 and	 on	 correlation	with	 other	
imaging	 techniques,	 e.g.	 the	 recognitions	 of	 FNH	 were	
made	on	the	basis	of	histopathologic	examinations	only	 in	
4	of	15	patients.	Verification	of	the	remaining	lesions	(in	11	
patients)	which	was	 carried	 out	 does	not	 guarantee	 com-
plete	 exclusion	of	 small	 adenomas	 imitating	 focal	nodular	
hyperplasia	in	the	group	of	tumors	diagnosed	as	FNH.	
Conclusion
The	protocol	 of	 qualitative-quantitative	 analysis	 proved	
to	 be	 very	useful	 for	 presurgical	 differentiation	 of	 focal	
lesions	in	liver,	as	it	enabled	discrimination	of	malignant	
and	 benign	 tumors	 group	 treated	 surgically	 with	 high	
	sensitivity	(95%)	and	specificity	(91%).
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